Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, April 17, 2025

Improving stroke recovery through nerve stimulation

 Why are we still researching this? Isn't there enough research already out there so we CAN WRITE EXACT PROTOCOLS ON THIS? Or is everyone in stroke so FUCKING INCOMPETENT they don't follow research at all? That's a question that our stroke medical 'professionals' need to answer, but they won't.

Let's see how long vagus nerve stimulation has been out there. And I'd do the non-invasive types.

Improving stroke recovery through nerve stimulation

Stroke care and research teams have joined forces to test a groundbreaking nerve stimulation therapy designed to improve hand and arm weakness in stroke survivors.

The innovative treatment, known as TRanscutaneous lImb reCovEry Post-Stroke (TRICEPS), delivers electrical pulses to a patient's brain via a portable, pacemaker-like device during rehabilitation therapy.

Janet Schmitt, AHP Consultant Stroke Practitioner, said:

“Around 110,000 people suffer with a stroke in the UK every year and one third of stroke survivors are left with permanent arm weakness, which can make daily activities difficult.

“Rehabilitation therapy is the main treatment for people recovering from a stroke, but the benefits are modest, and many stroke survivors have persisting arm weakness, limiting their ability to self-care, which in turn creates pressure on the NHS and social care.

“The TRICEPS trial will build on the results of a recent clinical trial, which showed that, when combined with therapy, stimulating damaged areas of the brain using TVNS improved arm recovery in stroke survivors to a greater degree than if only therapy alone was provided.

“The stimulation is triggered via a lightweight, wearable pacemaker-like device, which connects to a wired earpiece. It’s automatically activated as the patient’s arm is moved during therapy, while the connected earpiece gently tickles the ear, meaning participants can access the treatment at home and without the need for a surgical implant.”

Stroke care QUOTE

Led nationally by researchers from Sheffield Teaching Hospitals NHS Foundation Trust and the University of Sheffield, the trial is funded by the National Institute for Health and Care Research and the Medical Research Council. Stroke clinicians in Somerset are also actively recruiting patients to participate in the study, which is the first of its kind to investigate whether transcutaneous vagus nerve stimulation (TVNS) can enhance hand and arm recovery when used as a self-delivered treatment during stroke rehabilitation.

Researchers hope that the portable stimulation device will enable the revolutionary treatment to be provided to a larger number of stroke patients, making it cost-effective and scalable. Some patients will also be asked to wear the device while performing their usual daily activities for a period of 12 weeks.

No comments:

Post a Comment